The Community for Technology Leaders
RSS Icon
Issue No.05 - September/October (2011 vol.8)
pp: 1170-1182
Rui Chang , University of California, San Diego, San Diego
Robert Shoemaker , University of California, San Diego, San Diego
Wei Wang , University of California, San Diego, San Diego
Deciphering the biological networks underlying complex phenotypic traits, e.g., human disease is undoubtedly crucial to understand the underlying molecular mechanisms and to develop effective therapeutics. Due to the network complexity and the relatively small number of available experiments, data-driven modeling is a great challenge for deducing the functions of genes/proteins in the network and in phenotype formation. We propose a novel knowledge-driven systems biology method that utilizes qualitative knowledge to construct a Dynamic Bayesian network (DBN) to represent the biological network underlying a specific phenotype. Edges in this network depict physical interactions between genes and/or proteins. A qualitative knowledge model first translates typical molecular interactions into constraints when resolving the DBN structure and parameters. Therefore, the uncertainty of the network is restricted to a subset of models which are consistent with the qualitative knowledge. All models satisfying the constraints are considered as candidates for the underlying network. These consistent models are used to perform quantitative inference. By in silico inference, we can predict phenotypic traits upon genetic interventions and perturbing in the network. We applied our method to analyze the puzzling mechanism of breast cancer cell proliferation network and we accurately predicted cancer cell growth rate upon manipulating (anti)cancerous marker genes/proteins.
Dynamic Bayesian network, genetic network, phenotype prediction, genetic intervention, systems biology, breast cancer, cell proliferation.
Rui Chang, Robert Shoemaker, Wei Wang, "A Novel Knowledge-Driven Systems Biology Approach for Phenotype Prediction upon Genetic Intervention", IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol.8, no. 5, pp. 1170-1182, September/October 2011, doi:10.1109/TCBB.2011.18
[1] T. Bayes, “An Essay Towards Solving a Problem in the Doctrine of Chances,” Philosophical Trans. Royal Soc. of London, vol. 53, pp. 370-418, 1763.
[2] M.J. Beal, F. Falciani, Z. Ghahramani, C. Rangel, and D.L. Wild, “A Bayesian Approach to Reconstructing Genetic Regulatory Networks with Hidden Factors,” Bioinformatics, vol. 21, pp. 349-356, 2005.
[3] C.E. Caldon, R.J. Daly, R.L. Sutherland, and E.A. Musgrove, “Cell Cycle Control in Breast Cancer Cells,” J. Cellular Biochemistry, vol. 97, no. 2, pp. 261-274, 2006.
[4] R. Chang, “Consistent Modeling, Integration and Simulation of Molecular Interaction Networks in Space-Time Dimension,” Proc. Seventh IEEE Int'l Conf. Bioinformatics and Bioengineering (BIBE '07), pp. 1254-1259, 2007.
[5] R. Chang, W. Brauer, and M. Stetter, “Modeling Semantics of Inconsistent Qualitative Knowledge for Quantitative Bayesian Network Inference,” Neural Networks, vol. 21, nos. 2-3, pp. 182-192, 2008.
[6] R. Chang, M. Stetter, and W. Brauer, “Quantitative Inference by Qualitative Semantic Knowledge Mining with Bayesian Model Averaging,” IEEE Trans. Knowledge and Data Eng., vol. 20, no. 12, pp. 1587-1600, Dec. 2008.
[7] C. Chaouiya, E. Remy, P. Ruet, and D. Thieffry, “Petri Net Modelling of Biological Regulatory Networks,” Proc. 25th Int'l Conf. Applications and Theory of Petri Nets, 2004.
[8] C.-R. Chen, Y. Kang, and J. Massagué, “Defective Repression of c-MYC in Breast Cancer Cells: A Loss at the Core of the Transforming Growth Factor $\beta$ Growth Arrest Program,” Proc. Nat'l Academy of Sciences USA, vol. 98, no. 3, pp. 992-999, , 2001.
[9] C.-R. Chen, Y. Kang, P.M. Siegel, and J. Massague, “E2F4/5 and p107 as Smad Cofactors Linking the TGF-beta Receptor to c-myc Repression,” Cell, vol. 110, pp. 19-32, 2002.
[10] M.B. Datto, Y. Li, J. Panus, D.J. Howe, Y. Xiong, and X.-F. Wang, “Transforming Growth Factor Beta Induces the Cyclin-Dependent Kinase Inhibitor p21 through a p53-Independent Mechanism,” Proc. Nat'l Academy of Science USA, vol. 92, pp. 5545-5549, 1995.
[11] T. Dean and K. Kanazawa, “A Model for Reasoning about Persistence and Causation,” Computational Intelligence, vol. 5, pp. 142-150, 1989.
[12] L.B. Eckert, G.A. Repasky, A.S. Ulku, A. McFall, H. Zhou, C.I. Sartor, and C.J. Der, “Involvement of Ras Activation in Human Breast Cancer Cell Signaling, Invasion, and Anoikis,” Cancer Research, vol. 64, pp. 4585-4592, 2004.
[13] J. Eeckhoute, J.S. Carroll, T.R. Geistlinger, M.I. Torres-Arzayus, and M. Brown, “A Cell-Type-Specific Transcriptional Network Required for Estrogen Regulation of Cyclin D1 and Cell Cycle Progression in Breast Cancer,” Genes & Development, vol. 20, no. 18, pp. 2513-2526,, Sept. 2006.
[14] N. Friedman, “Learning Belief Networks in the Presence of Missing Values and Hidden Variables,” Proc. 14th Int'l Conf. Machine Learning (ICML '97), pp. 125-133, 1997.
[15] N. Friedman, “Inferring Cellular Networks Using Probabilistic Graphical Models,” Science, vol. 303, pp. 799-805, 2004.
[16] N. Friedman and M. Goldszmidt, “Learning Bayesian Networks with Local Structure,” Learning in Graphical Models, MIT Press, 1999.
[17] N. Friedman, M. Linial, I. Nachman, and D. Peer, “Using Bayesian Networks to Analyze Expression Data,” J. Computational Biology, vol. 7, pp. 601-620, 2000.
[18] F. Geier, J. Timmer, and C. Fleck1, “Reconstructing Gene-Regulatory Networks from Time Series, Knock-Out Data, and Prior Knowledge,” BMC Systems Biology, vol. 1, article no. 11, 2007.
[19] D. Gonze and A. Goldbeter, “Circadian Rhythms and Molecular Noise,” Chaos: An Interdisciplinary J. Nonlinear Science, vol. 16, no. 2, p. 026110, 2006.
[20] J.S. Gutkind, Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Diseases (Cancer Drug Discovery and Development, 5). Humana Press, 2000.
[21] G.J. Hannon and D. Beach, “pl5INK4B is a Potential Effector of TGF-[Beta]-Induced Cell Cycle Arrest,” Nature, vol. 371, pp. 257-261, 1994.
[22] A.J. Hartemink, D.K. Gifford, T. Jaakkola, and R.A. Young, “Combining Location and Expression Data for Principled Discovery of Genetic Regulatory Network Models,” Proc. Pacific Symp. Biocomputing, pp. 437-449, 2002.
[23] D. Heckerman, “Learning Bayesian Networks: The Combination of Knowledge and Statistical Data,” technical report, KDD Workshop, 1994.
[24] D. Heckerman, “A Tutorial on Learning with Bayesian Networks,” technical report, Microsoft Research, 1996.
[25] W. Hu, C.J. Bellone, and J.J. Baldassare, “RhoA Stimulates p27Kip Degradation through Its Regulation of Cyclin E/CDK2 Activity,” J. Biological Chemistry, vol. 274, pp. 3396-3401, 1999.
[26] G. Karlebach and R. Shamir, “Modelling and Analysis of Gene Regulatory Networks,” Nature Rev. Molecular Cell Biology, vol. 9, pp. 770-780, 2008.
[27] S. Kauffman, C. Peterson, B. Samuelsson, and C. Troein, “Random Boolean Network Models and the Yeast Transcriptional Network,” Proc. Nat'l Academy of Sciences USA, vol. 100, pp. 14796-14799, 2003.
[28] K. Keyomarsi and A.B. Pardee, “Redundant Cyclin Overexpression and Gene Amplification in Breast Cancer Cells,” Proc. Nat'l Academy of Sciences USA, vol. 90, pp. 1112-1116, 1993.
[29] S.Y. Kim, S. Imoto, and S. Miyano, “Inferring Gene Networks from Time Series Microarray Data Using Dynamic Bayesian Networks,” Briefings in Bioinformatics, vol. 4, pp. 228-235, 2003.
[30] I. Koch, M. Schueler, and M. Heiner, “STEPP—Search Tool for Exploration of Petri Net Paths: A New Tool for Petri Net-Based Path Analysis in Biochemical Networks,” In Silico Biology, vol. 5, pp. 129-137, 2005.
[31] R. Kuffner, R. Zimmer, and T. Lengauer, “Pathway Analysis in Metabolic Databases via Differential Metabolic Display (DMD),” Bioinformatics, vol. 16, pp. 825-836, 2000.
[32] S. Lauritzen and D. Spiegelhalter, “Local Computations with Probabilities on Graphical Structures and Their Application to Expert Systems,” J. Royal Statistical Soc. Series B, vol. 50, pp. 157-224, 1988.
[33] F. Li, T. Long, Y. Lu, Q. Ouyang, and C. Tang, “The Yeast Cell-Cycle Network is Robustly Designed,” Proc. Nat'l Academy of Sciences USA, vol. 101, pp. 4781-4786, 2004.
[34] A.A. Margolin, I. Nemenman, K. Basso, C. Wiggins, G. Stolovitzky, R.D. Favera, and A. Califano, “ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context,” BMC Bioinformatics, vol. 7 (Suppl 1), p. S7, 2006.
[35] K. Murphy, “Dynamic Bayesian Networks: Representation, Inference and Learning,” PhD dissertation, Univ. of California, Berkeley, 2002.
[36] Y. Pan, T. Durfee, J. Bockhorst, and M. Craven, “Connecting Quantitative Regulatory-Network Models to the Genome,” Bioinformatics, vol. 23, pp. 367-376, 2007.
[37] J. Pearl, Probabilistic Reasoning in Intelligent Systems: Networks of Plausible Inference. Morgan Kaufmann Publishers, 1988.
[38] K. Polyak, M.-H. Lee, H. Erdjument-Bromage, A. Koff, J.M. Roberts, P. Tempst, and J. Massague, Cell, 1994.
[39] V.N. Reddy, M.N. Liebman, and M.L. Mavrovouniotis, “Qualitative Analysis of Biochemical Reaction Systems,” Computers in Biology and Medicine, vol. 26, pp. 9-24, 1996.
[40] I. Reynisdottir, K. Polyak, A. Iavarone, and J. Massague, “Kip/Cip and Ink4 Cdk Inhibitors Cooperate to Induce Cell Cycle Arrest in Response to TGF-Beta,” Genes and Development, vol. 9, pp. 1831-1845, 1995.
[41] C.N. Robson, V. Gnanapragasam, R.L. Byrne, and A.T. Collins, “Transforming Growth Factor-Beta1 Up-Regulates p15, p21 and p27 and Blocks Cell Cycling in G1 in Human Prostate Epithelium,” J. Endocrinology, vol. 160, pp. 257-266, 1999.
[42] K. Sachs, O. Perez, D. Peer, D.A. Lauffenburger, and G.P. Nolan, “Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data,” Science, vol. 308, pp. 523-529, 2005.
[43] E. Segal, M. Shapira, R. A, D. Pe'er, D. Botstein, D. Koller, and N. Friedman, “Module Networks: Identifying Regulatory Modules and Their Condition-Specific Regulators from Gene Expression Data,” Nature Genetics, vol. 34, pp. 166-176, 2003.
[44] E. Segal, H. Wang, and D. Koller, “Discovering Molecular Pathways from Protein Interaction and Gene Expression Data,” Bioinformatics, vol. 19, pp. 264-272, 2003.
[45] J. Seoane, H.-V. Le, and J. Massague, “Myc Suppression of the p21Cip1 Cdk Inhibitor Influences the Outcome of the p53 Response to DNA Damage,” Nature, vol. 419, pp. 729-734, 2002.
[46] J. Seoane, C. Pouponnot, P. Staller, M. Schader, M. Eilers, and J. Massague, “TGF-Beta Influences Myc, Miz-1 and Smad to Control the CDK Inhibitor p15INK4b,” Nature Cell Biology, vol. 3, pp. 400-408, 2001.
[47] S.E. Seton-Rogers, Y. Lu, L.M. Hines, M. Koundinya, J. LaBaer, S.K. Muthuswamy, and J.S. Brugge, “Cooperation of the ErbB2 Receptor and Transforming Growth Factor Beta in Induction of Migration and Invasion in Mammary Epithelial Cells,” Proc. Nat'l Academy of Sciences USA, vol. 101, pp. 1257-1262, 2003.
[48] P.M. Siegel and J. Massagué, “Cytostatic and Apoptotic Actions of TGF-Beta in Homeostasis and Cancer,” Nature Rev. Cancer, vol. 3, no. 11, pp. 807-821, 2003.
[49] K.J. Sweeney, A. Swarbrick, R.L. Sutherland, and E.A. Musgrove, “Lack of Relationship between CDK Activity and G1 Cyclin Expression in Breast Cancer Cells,” Oncogene, vol. 16, pp. 2865-2878, 1998.
[50] O.G. Troyanskaya, K. Dolinski, A.B. Owen, R.B. Altman, and D. Botstein, “A Bayesian Framework for Combining Heterogeneous Data Sources for Gene Function Prediction (in Saccharomyces cerevisiae),” Proc. Nat'l Academy of Sciences USA, vol. 100, pp. 8348-8353, 2003.
[51] A.V. Werhli and D. Husmeier, “Gene Regulatory Network Reconstruction by Bayesian Integration of Prior Knowledge and/or Different Experimental Conditions,” J. Bioinformatics and Computational Biology, vol. 6, pp. 543-572, 2008.
[52] Q. Zhou, M. Stetler-Stevenson, and P.S. Steeg, “Inhibition of Cyclin D Expression in Human Breast Carcinoma Cells by Retinoids In Vitro,” Oncogene, vol. 15, pp. 107-115, 1997.
20 ms
(Ver 2.0)

Marketing Automation Platform Marketing Automation Tool